DiscoverBlood & CancerReal-world checkpoint inhibitor results not as good as trial results
Real-world checkpoint inhibitor results not as good as trial results

Real-world checkpoint inhibitor results not as good as trial results

Update: 2020-11-10
Share

Description

Hematology Oncology News: 

  1. IMRT new standard of care for high-risk cervical cancer: https://bit.ly/3k7ji3y
  2. Real-world results with checkpoint inhibitors found inferior to trial results: https://bit.ly/35cIt0v
  3. Are HMAS appropriate for posttransplant maintenance in acute leukemias?: https://bit.ly/3lfqsE7

You can email the show at podcasts@mdedge.com.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Real-world checkpoint inhibitor results not as good as trial results

Real-world checkpoint inhibitor results not as good as trial results

Medscape Professional Network